(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENETYPE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GENETYPE

ST13

US500000079264799

Class

1, 5, 9, 42, 44

Filing

79264799

Registration

6291484

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

03/17/2026

Trademark type

Combined

Nice classes

1, 5, 9, 42, 44

Filing date

03/06/2019

Registration date

03/16/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/16/2021

Last transaction

03/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

98

Owner location

AU

Examiner

MAHONEY, PAULA M

Law office

N10

Current location

TMO LAW OFFICE 119

Mark description

The mark consists of the stylized wording "GENETYPE" to the right of a stylized design of an oblong shape, similar to the numeral "8". There is a single dot above and to the right of the oblong shape.

Holders and representatives

Holders

RHY Genetype Pty Ltd
Genetic Technologies Limited

Representatives

Charles G. Zug Nelson Mullins Riley & Scarborough LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test kits comprised primarily of reagents and assays for scientific use

Class 5

Pharmaceutical and veterinary preparations for the treatment of a wide variety of diseasesdiagnostic kits consisting primarily of primersprobesbuffersreagents for use in genetic testing for medical purposes; diagnostic preparations and reagents for medical use; diagnostic test kits comprised primarily of reagents and assays for medical use

Class 9

Apparatus and instrumentsDNA genotyping arraysDNA sequencing instrumentscomputer hardwarerecorded computer programsdownloadable software all featuring proprietary algorithms to analyse DNA; scientific and teaching apparatus and instrumentsdownloadable electronic publications in the nature of bookspamphletsbrochuresnewslettersjournalsmagazines and periodicals in the field of risk assessment testing; recorded computer software and downloadable computer software to analyse and record the results of DNA testing; equipment to analyse and record the results of DNA testinglaboratory devices for detecting genetic and protein substancesDNA genotyping arraysDNA sequencing instrumentsrecorded software for scientific analysis of genetic and protein sequencesassessment kits comprised primarily of laboratory swabs and also containing bar-coded specimen envelopeinstruction sheetspecimen information formpre-paid mailing envelope

Class 42

Biotechnology research and development services for othersincluding genetic association studiesgenome mappinggenome analysis and genome scanningpharmaceutical drug and therapeutics development; product developmentincluding consumer health product development and consultation in the field of genomics and pharmaceutical drug development; provision of scientific and medical research in the fields of DNA typing and profiling; computer programming services for DNA typing and profiling for use in medical research * ; genetic testing for medical purposes and forensic biological screening of DNA for medical purposes *

Class 44

Medical diagnostic servicesreagent sample testing and diagnostic services for others in the fields of science and medical research; genetic testing for medical purposesgenome mappinggenome analysisgenome scanning; provision of medical servicesveterinary servicesgenetic testing for medical purposes and forensic biological screening of DNA for medical purposes ; providing medical diagnostic services and veterinary diagnostic services

Publications

History of USPTO decisions and trademark events.

45 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/16/2026

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/21/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

04/26/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

12/12/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/04/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/16/2021

FIMP

FINAL DISPOSITION PROCESSED

06/16/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/16/2021

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

04/12/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/12/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/12/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

03/16/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/28/2021

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/30/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/13/2021

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/13/2021

GPNX

NOTIFICATION PROCESSED BY IB

01/10/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/29/2020

PUBO

PUBLISHED FOR OPPOSITION

12/29/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/23/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/23/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/09/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/02/2020

GNRT

NON-FINAL ACTION E-MAILED

06/02/2020

CNRT

NON-FINAL ACTION WRITTEN

06/02/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/01/2020

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

03/31/2020

ALIE

ASSIGNED TO LIE

03/19/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/14/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/12/2020

RFNT

REFUSAL PROCESSED BY IB

09/28/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/12/2019

RFRR

REFUSAL PROCESSED BY MPU

09/12/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/03/2019

CNRT

NON-FINAL ACTION WRITTEN

09/02/2019

MAFR

APPLICATION FILING RECEIPT MAILED

08/21/2019

DOCK

ASSIGNED TO EXAMINER

08/17/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/17/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/08/2019

Continuous trademark protection

Get notified about every new filing that threatens GENETYPE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.